earnings
confidence high
sentiment positive
materiality 0.75
LifeMD Q1 revenue up 49% to $65.7M; first GAAP profit; raises FY 2025 guidance
LifeMD, Inc.
2025-Q3 EPS
reported -$0.02
vs consensus -$0.05
▲ beat
(+58.0%)
- Total revenue $65.7M (+49% YoY); telehealth revenue up 70% to $55.8M.
- GAAP net income $0.6M ($0.01 diluted EPS), first-ever positive GAAP EPS.
- Adj. EBITDA $8.7M (vs. $0.1M); telehealth adj. EBITDA $5.3M (vs. -$1.3M).
- FY 2025 guidance raised: revenue $268-275M, adj. EBITDA $31-33M.
- Partnered with LillyDirect/NovoCare for branded GLP-1 access (Zepbound, Wegovy).